Missouri Lawmakers Approve Psychedelics Bills To Expand Access To And Research On Psilocybin And Ibogaine
Amendment To Delay Hemp THC Ban Won’t Get A Vote At Farm Bill Hearing, Key GOP Congressional Committee Chair Signals
Oklahoma Lawmakers Vote To Extend Medical Marijuana Business License Moratorium
Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows
Legalizing Marijuana In Pennsylvania Would Generate Almost Half A Billion Dollars In Revenue By 2028 Under Governor’s Plan, State Analysis Finds
Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most
AI Models Like ChatGPT Can Generate ‘Convincingly Realistic’ Psychedelic Experiences When Virtually Dosed, Study Shows
Cannabis-Infused Drinks Offer Consumers A ‘Harm Reduction’ Alternative To Alcohol, Study Shows
Marijuana Use Isn’t A ‘Red Flag’ In The Dating Scene, Three In Four Americans Say In New Survey
10 Million US Adults Microdosed Psychedelics Last Year, New Report Shows
DEA Promotes Anti-Marijuana PSA Contest Inviting Students To Warn Peers About THC Dangers On 4/20
Largest Entertainment Arena In US Partners With Cannabis Businesses To Sell THC Drinks At Concerts And Live Events
Woody Harrelson Got Kicked Out Of Two Bars For Smoking Marijuana With Matthew McConaughey’s Mom
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
Montana Retailers Have Sold More Than $1 Billion Worth Of Recreational Marijuana Since Legalization Took Effect
Pre-Rolls Are A Key Driver Of The Cannabis Retail Market’s Success (Op-Ed)
Massachusetts Hits $10 Billion Marijuana Sales Milestone, With Top Official Saying Consumption Lounges Will Bolster Industry In 2026
Ohio Dispensaries Sold More Than $1 Billion Worth Of Legal Marijuana In 2025
Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows
ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)
Congress will consider hemp THC product ban delay next week (Newsletter: February 25, 2026)
Dr. Oz warns about cannabis as alcohol alternative (Newsletter: February 24, 2026)
DOJ defends cannabis user gun ban, even if rescheduling happens (Newsletter: February 23, 2026)
Cannabis legalization on the ballot in Texas (Newsletter: February 20, 2026)
Published
on
By
Missouri lawmakers have approved legislation aimed at expanding therapeutic access to and research on psychedelics such as psilocybin and ibogaine for adults and military veterans.
On Wednesday, members of the House Emerging Issues Committee passed two psychedelics proposals—combining two psilocybin- and two ibogaine-focused bills from Reps. Matthew Overcast (R) and Rep. Richard West (R)—that would take a series of steps to fund psychedelics studies, prepare for federal approval of novel therapeutics and create regulated psilocybin programs through which the substance could be administered to eligible patients.
The ibogaine measures as introduced by both lawmakers were identical, but there were certain differences in the psilocybin bills that were merged. The final text of the merged legislation hasn’t been released yet, however, so it’s currently unclear what made it in the deal.
Here’s an overview of all four of the Missouri psychedelics bills that were taken up in committee:
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
West also sponsored a bill last session to provide therapeutic access to psilocybin for military veterans that ultimately wasn’t enacted into law.
The passage of the bills through committee this session comes months after bipartisan and bicameral Missouri legislators pre-filed a series of drug policy reform proposals that range from providing early release for people incarcerated for certain cannabis-related convictions to promoting access to alternative therapies such as psilocybin.
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. He’s covered drug policy for more than a decade—specializing in state and federal marijuana and psychedelics issues at publications that also include High Times, VICE and attn. In 2022, Jaeger was named Benzinga’s Cannabis Policy Reporter of the Year.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell